Cargando…
Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats
BACKGROUND: Antineoplastic drug cisplatin remains the drug of choice for various solid tumours including breast cancer. But dose dependent nephrotoxicity is the major drawback in majority of platinum based chemotherapy regimens. Recent reports have shown that inflammatory pathways are the main offen...
Autores principales: | Tikoo, Kulbhushan, Kumar, Parveen, Gupta, Jeena |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676298/ https://www.ncbi.nlm.nih.gov/pubmed/19356226 http://dx.doi.org/10.1186/1471-2407-9-107 |
Ejemplares similares
-
Anticancer activity of Astragalus ovinus against 7, 12 dimethyl benz (a) anthracene (DMBA)-induced breast cancer in rats
por: Mehraban, Fouad, et al.
Publicado: (2020) -
Restraint stress abates the antioxidant potential of melatonin on dimethyl benz (a) anthracene (DMBA) induced carcinogenesis
por: Muqbil, Irfana, et al.
Publicado: (2020) -
Quercetin attenuates the development of 7, 12-dimethyl benz (a) anthracene (DMBA) and croton oil-induced skin cancer in mice
por: Ali, Huma, et al.
Publicado: (2015) -
Potential chemopreventive effects of Broccoli extract supplementation against 7, 12 dimethyl Benz(a)anthracene (DMBA) -induced toxicity in female rats
por: Allam, Aya M., et al.
Publicado: (2023) -
Dimethyl-Benz(a)anthracene: A mammary carcinogen and a neuroendocrine disruptor
por: Kerdelhué, Bernard, et al.
Publicado: (2016)